Avid Bioservices, Inc. (CDMO)
USD 12.49
(0.0%)
USD 12.49
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 275.66 Million USD | 5.38% |
| 2023 | 261.58 Million USD | 2.45% |
| 2022 | 255.31 Million USD | 35.97% |
| 2021 | 187.77 Million USD | 185.7% |
| 2020 | 65.72 Million USD | 159.5% |
| 2019 | 25.32 Million USD | -36.72% |
| 2018 | 40.02 Million USD | -37.98% |
| 2017 | 64.53 Million USD | 9.43% |
| 2016 | 58.96 Million USD | 53.45% |
| 2015 | 38.42 Million USD | 68.21% |
| 2014 | 22.84 Million USD | 7.27% |
| 2013 | 21.29 Million USD | 13.41% |
| 2012 | 18.77 Million USD | -2.94% |
| 2011 | 19.34 Million USD | 21.47% |
| 2010 | 15.92 Million USD | -28.34% |
| 2009 | 22.22 Million USD | 197.86% |
| 2008 | 7.46 Million USD | 24.2% |
| 2007 | 6 Million USD | 18.97% |
| 2006 | 5.05 Million USD | 8.95% |
| 2005 | 4.63 Million USD | 5.87% |
| 2004 | 4.37 Million USD | 33.97% |
| 2003 | 3.26 Million USD | 17.43% |
| 2002 | 2.78 Million USD | -46.62% |
| 2001 | 5.21 Million USD | -39.89% |
| 2000 | 8.67 Million USD | -8.69% |
| 1999 | 9.5 Million USD | 43.94% |
| 1998 | 6.6 Million USD | 60.98% |
| 1997 | 4.1 Million USD | 127.78% |
| 1996 | 1.8 Million USD | 20.0% |
| 1995 | 1.5 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 270.96 Million USD | 7.64% |
| 2024 Q1 | 251.73 Million USD | -3.76% |
| 2024 FY | 275.66 Million USD | 5.38% |
| 2024 Q4 | 275.66 Million USD | 0.22% |
| 2024 Q3 | 275.05 Million USD | 1.51% |
| 2023 FY | 261.58 Million USD | 2.45% |
| 2023 Q1 | 272.22 Million USD | 6.62% |
| 2023 Q2 | 260.65 Million USD | -4.25% |
| 2023 Q3 | 265.03 Million USD | 1.68% |
| 2023 Q4 | 261.58 Million USD | -1.3% |
| 2022 FY | 255.31 Million USD | 35.97% |
| 2022 Q1 | 225.89 Million USD | 20.3% |
| 2022 Q2 | 250.52 Million USD | 10.9% |
| 2022 Q3 | 257.52 Million USD | 2.79% |
| 2022 Q4 | 255.31 Million USD | -0.86% |
| 2021 FY | 187.77 Million USD | 185.7% |
| 2021 Q4 | 187.77 Million USD | 126.76% |
| 2021 Q3 | 82.8 Million USD | 28.97% |
| 2021 Q2 | 64.2 Million USD | 8.79% |
| 2021 Q1 | 59.02 Million USD | -10.2% |
| 2020 Q4 | 65.72 Million USD | 13.05% |
| 2020 FY | 65.72 Million USD | 159.5% |
| 2020 Q1 | 52.38 Million USD | 106.84% |
| 2020 Q2 | 56.06 Million USD | 7.02% |
| 2020 Q3 | 58.13 Million USD | 3.7% |
| 2019 Q4 | 25.32 Million USD | 9.9% |
| 2019 FY | 25.32 Million USD | -36.72% |
| 2019 Q1 | 27.96 Million USD | -30.13% |
| 2019 Q2 | 25.42 Million USD | -9.07% |
| 2019 Q3 | 23.04 Million USD | -9.36% |
| 2018 Q3 | 38.33 Million USD | 7.33% |
| 2018 Q4 | 40.02 Million USD | 4.39% |
| 2018 FY | 40.02 Million USD | -37.98% |
| 2018 Q1 | 44.26 Million USD | -31.4% |
| 2018 Q2 | 35.72 Million USD | -19.31% |
| 2017 Q3 | 71.3 Million USD | 5.23% |
| 2017 FY | 64.53 Million USD | 9.43% |
| 2017 Q1 | 64.67 Million USD | 9.67% |
| 2017 Q2 | 67.75 Million USD | 4.78% |
| 2017 Q4 | 64.53 Million USD | -9.5% |
| 2016 Q3 | 59.11 Million USD | 36.12% |
| 2016 Q4 | 58.96 Million USD | -0.25% |
| 2016 Q2 | 43.43 Million USD | 18.71% |
| 2016 Q1 | 36.58 Million USD | -4.8% |
| 2016 FY | 58.96 Million USD | 53.45% |
| 2015 FY | 38.42 Million USD | 68.21% |
| 2015 Q4 | 38.42 Million USD | 31.04% |
| 2015 Q1 | 22.01 Million USD | -3.64% |
| 2015 Q2 | 22.66 Million USD | 2.93% |
| 2015 Q3 | 29.32 Million USD | 29.42% |
| 2014 Q2 | 19.45 Million USD | -6.36% |
| 2014 Q4 | 22.84 Million USD | 6.69% |
| 2014 FY | 22.84 Million USD | 7.27% |
| 2014 Q1 | 20.78 Million USD | -2.43% |
| 2014 Q3 | 21.41 Million USD | 10.05% |
| 2013 FY | 21.29 Million USD | 13.41% |
| 2013 Q4 | 21.29 Million USD | 7.79% |
| 2013 Q3 | 19.75 Million USD | -17.19% |
| 2013 Q2 | 23.85 Million USD | -13.5% |
| 2013 Q1 | 27.58 Million USD | 46.88% |
| 2012 Q3 | 16.53 Million USD | 11.87% |
| 2012 Q1 | 15.21 Million USD | -21.35% |
| 2012 FY | 18.77 Million USD | -2.94% |
| 2012 Q2 | 14.78 Million USD | -2.88% |
| 2012 Q4 | 18.77 Million USD | 13.57% |
| 2011 Q1 | 16.46 Million USD | 3.37% |
| 2011 Q4 | 19.34 Million USD | 9.61% |
| 2011 FY | 19.34 Million USD | 21.47% |
| 2011 Q2 | 17.14 Million USD | 4.13% |
| 2011 Q3 | 17.65 Million USD | 2.96% |
| 2010 Q1 | 20.98 Million USD | -5.57% |
| 2010 FY | 15.92 Million USD | -28.34% |
| 2010 Q4 | 15.92 Million USD | 7.08% |
| 2010 Q3 | 14.87 Million USD | -24.15% |
| 2010 Q2 | 19.61 Million USD | -6.56% |
| 2009 Q4 | 22.22 Million USD | 16.77% |
| 2009 FY | 22.22 Million USD | 197.86% |
| 2009 Q3 | 19.03 Million USD | 24.88% |
| 2009 Q2 | 15.24 Million USD | 26.72% |
| 2009 Q1 | 12.02 Million USD | 61.19% |
| 2008 Q1 | 5.2 Million USD | -13.33% |
| 2008 FY | 7.46 Million USD | 24.2% |
| 2008 Q2 | 6.99 Million USD | 34.28% |
| 2008 Q3 | 6.71 Million USD | -4.03% |
| 2008 Q4 | 7.46 Million USD | 11.21% |
| 2007 FY | 6 Million USD | 18.97% |
| 2007 Q1 | 4.36 Million USD | -13.56% |
| 2007 Q3 | 6.26 Million USD | 20.74% |
| 2007 Q2 | 5.18 Million USD | 18.88% |
| 2007 Q4 | 6 Million USD | -4.1% |
| 2006 Q1 | 4.25 Million USD | -8.2% |
| 2006 FY | 5.05 Million USD | 8.95% |
| 2006 Q2 | 4.49 Million USD | 5.57% |
| 2006 Q4 | 5.05 Million USD | 13.69% |
| 2006 Q3 | 4.44 Million USD | -1.11% |
| 2005 Q3 | 4.96 Million USD | -4.08% |
| 2005 Q4 | 4.63 Million USD | -6.57% |
| 2005 Q2 | 5.17 Million USD | -4.22% |
| 2005 FY | 4.63 Million USD | 5.87% |
| 2005 Q1 | 5.4 Million USD | 23.34% |
| 2004 Q2 | 2.41 Million USD | -18.74% |
| 2004 Q4 | 4.37 Million USD | 7.75% |
| 2004 Q3 | 4.06 Million USD | 67.96% |
| 2004 Q1 | 2.97 Million USD | -8.9% |
| 2004 FY | 4.37 Million USD | 33.97% |
| 2003 Q2 | 4.97 Million USD | 46.94% |
| 2003 Q3 | 4.23 Million USD | -14.87% |
| 2003 Q4 | 3.26 Million USD | -22.87% |
| 2003 FY | 3.26 Million USD | 17.43% |
| 2003 Q1 | 3.38 Million USD | 21.7% |
| 2002 Q2 | 1.98 Million USD | 6.25% |
| 2002 Q1 | 1.87 Million USD | -64.1% |
| 2002 FY | 2.78 Million USD | -46.62% |
| 2002 Q4 | 2.78 Million USD | 23.31% |
| 2002 Q3 | 2.25 Million USD | 13.47% |
| 2001 Q4 | 5.21 Million USD | -28.72% |
| 2001 FY | 5.21 Million USD | -39.89% |
| 2001 Q3 | 7.31 Million USD | 3.71% |
| 2001 Q1 | 9.65 Million USD | 11.34% |
| 2001 Q2 | 7.05 Million USD | -26.97% |
| 2000 Q1 | 9.3 Million USD | -2.11% |
| 2000 Q2 | 9.8 Million USD | 5.38% |
| 2000 Q3 | 10.2 Million USD | 4.08% |
| 2000 Q4 | 8.67 Million USD | -14.96% |
| 2000 FY | 8.67 Million USD | -8.69% |
| 1999 FY | 9.5 Million USD | 43.94% |
| 1999 Q1 | 6.9 Million USD | 4.55% |
| 1999 Q2 | 5.1 Million USD | -26.09% |
| 1999 Q3 | 2.7 Million USD | -47.06% |
| 1999 Q4 | 9.5 Million USD | 251.85% |
| 1998 FY | 6.6 Million USD | 60.98% |
| 1998 Q3 | 5.8 Million USD | 7.41% |
| 1998 Q4 | 6.6 Million USD | 13.79% |
| 1998 Q2 | 5.4 Million USD | 28.57% |
| 1998 Q1 | 4.2 Million USD | 2.44% |
| 1997 Q4 | 4.1 Million USD | 41.38% |
| 1997 Q3 | 2.9 Million USD | 3.57% |
| 1997 FY | 4.1 Million USD | 127.78% |
| 1997 Q2 | 2.8 Million USD | 55.56% |
| 1997 Q1 | 1.8 Million USD | 0.0% |
| 1996 Q2 | 1.4 Million USD | 0.0% |
| 1996 Q3 | 600 Thousand USD | -57.14% |
| 1996 FY | 1.8 Million USD | 20.0% |
| 1996 Q4 | 1.8 Million USD | 200.0% |
| 1995 Q4 | 1.5 Million USD | 0.0% |
| 1995 FY | 1.5 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbCellera Biologics Inc. | 335.77 Million USD | 17.901% |
| Alkermes plc | 933.53 Million USD | 70.471% |
| Agenus Inc. | 462.29 Million USD | 40.37% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 93.194% |
| Aptorum Group Limited | 5.25 Million USD | -5144.089% |
| Ardelyx, Inc. | 130.76 Million USD | -110.815% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | 42.376% |
| Bicycle Therapeutics plc | 224.41 Million USD | -22.84% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -111.71% |
| ChromaDex Corporation | 26.5 Million USD | -939.943% |
| Chimerix, Inc. | 19.74 Million USD | -1296.141% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -683.657% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -279.881% |
| CRISPR Therapeutics AG | 346.76 Million USD | 20.504% |
| Precision BioSciences, Inc. | 140.92 Million USD | -95.62% |
| Dyadic International, Inc. | 2.34 Million USD | -11677.407% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -1595.062% |
| Fortress Biotech, Inc. | 165.93 Million USD | -66.126% |
| Lantern Pharma Inc. | 2.73 Million USD | -9962.044% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -285.658% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -7712.113% |
| Incyte Corporation | 1.59 Billion USD | 82.687% |
| IO Biotech, Inc. | 17.55 Million USD | -1470.221% |
| Jaguar Health, Inc. | 45.86 Million USD | -501.029% |
| Novavax, Inc. | 2.57 Billion USD | 89.283% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -664.513% |
| Opthea Limited | 264.6 Million USD | -4.182% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -110.905% |
| ContextLogic Inc. | 206 Million USD | -33.819% |
| MiMedx Group, Inc. | 96.33 Million USD | -186.17% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -474.045% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -7711.755% |
| NextCure, Inc. | 14.99 Million USD | -1738.154% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -6720.089% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -4028.621% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -489.803% |
| Vaxcyte, Inc. | 167.44 Million USD | -64.628% |
| PDS Biotechnology Corporation | 33.25 Million USD | -728.849% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -17.199% |
| Pharming Group N.V. | 244.07 Million USD | -12.945% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -2212.263% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -115.718% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -4072.186% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -4072.186% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -234.415% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -4049.752% |
| Acelyrin, Inc. | 86.35 Million USD | -219.234% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -21117.619% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -1817.157% |
| Summit Therapeutics Inc. | 125.25 Million USD | -120.082% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -2808.197% |
| Senti Biosciences, Inc. | 52.57 Million USD | -424.373% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -300.814% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -81.945% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -13993.456% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -20540.568% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -21.53% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -2842.97% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -21.202% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | 44.254% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -2425.82% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -902.028% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -2177.364% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | 43.348% |
| Immix Biopharma, Inc. | 3.72 Million USD | -7306.88% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -629.049% |
| MEI Pharma, Inc. | 8.35 Million USD | -3199.437% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -850.088% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | 20.689% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -88.983% |
| Fortress Biotech, Inc. | 165.93 Million USD | -66.126% |
| Precigen, Inc. | 41.64 Million USD | -561.963% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -452.109% |
| AlloVir, Inc. | 45.01 Million USD | -512.391% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -111.504% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -100.049% |
| ImmuCell Corporation | 18.81 Million USD | -1365.148% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -876.646% |
| Onconetix, Inc. | 23.18 Million USD | -1089.204% |
| PureTech Health plc | 125.58 Million USD | -119.511% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -2980.089% |
| Elevation Oncology, Inc. | 34.28 Million USD | -704.119% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -11174.765% |
| Seer, Inc. | 39.36 Million USD | -600.287% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -345.819% |
| Innoviva, Inc. | 568.55 Million USD | 51.514% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -912.443% |
| ESSA Pharma Inc. | 3.49 Million USD | -7787.336% |
| GlycoMimetics, Inc. | 6.9 Million USD | -3893.988% |
| GT Biopharma, Inc. | 6.63 Million USD | -4056.008% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -4.266% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -1.242% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -228.075% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -2720.422% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -914.642% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -8445.797% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -273.701% |
| Aptose Biosciences Inc. | 15.8 Million USD | -1643.774% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -2397.064% |
| Soligenix, Inc. | 7.27 Million USD | -3689.301% |
| Century Therapeutics, Inc. | 175.94 Million USD | -56.682% |
| Kura Oncology, Inc. | 51.66 Million USD | -433.599% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -127.295% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -6569.925% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -4068.038% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -9.133% |
| Autolus Therapeutics plc | 263.9 Million USD | -4.456% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -2529.918% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -210.224% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -487.791% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | 21.875% |
| GRI Bio, Inc. | 2.69 Million USD | -10121.283% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -33950.532% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -786.649% |
| IGM Biosciences, Inc. | 220.17 Million USD | -25.203% |
| INmune Bio, Inc. | 18.86 Million USD | -1361.499% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -7.482% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -934.719% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -10040.796% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -8303.831% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -371.59% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -186.679% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -4.13% |
| Coherus BioSciences, Inc. | 823.02 Million USD | 66.506% |
| Verastem, Inc. | 71.18 Million USD | -287.256% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -460.574% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -614.573% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -463.37% |
| Histogen Inc. | 5.69 Million USD | -4738.827% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -6185.746% |
| Surrozen, Inc. | 8.14 Million USD | -3284.506% |
| Organovo Holdings, Inc. | 2.74 Million USD | -9931.587% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -87732.077% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -390.252% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -1569.501% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -439.436% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -33238.534% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -117.532% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -2449.274% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -82.696% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -10472.747% |
| Apollomics, Inc. | 14.15 Million USD | -1847.771% |
| Amarin Corporation plc | 279.58 Million USD | 1.402% |
| Mesoblast Limited | 188.79 Million USD | -46.012% |
| Turnstone Biologics Corp. | 14.14 Million USD | -1848.459% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -52.481% |
| Synaptogenix, Inc. | 5.52 Million USD | -4885.434% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -4046.631% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -62.055% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -3121.477% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -15586.19% |
| Exelixis, Inc. | 678.44 Million USD | 59.368% |
| Better Therapeutics, Inc. | 23.84 Million USD | -1056.229% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -68.043% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | 53.608% |
| NLS Pharmaceutics AG | 10.68 Million USD | -2481.112% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -16878.645% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -608.167% |
| Gritstone bio, Inc. | 125.91 Million USD | -118.925% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -1778.359% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -5317.336% |
| Insmed Incorporated | 1.66 Billion USD | 83.411% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -3482.885% |
| MediWound Ltd. | 27.18 Million USD | -913.97% |
| OmniAb, Inc. | 87.4 Million USD | -215.41% |
| Alector, Inc. | 487.66 Million USD | 43.472% |
| Seres Therapeutics, Inc. | 403.45 Million USD | 31.673% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -1396.163% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -618.391% |
| Zai Lab Limited | 240.17 Million USD | -14.777% |
| Revance Therapeutics, Inc. | 630.05 Million USD | 56.247% |
| Aura Biosciences, Inc. | 29.22 Million USD | -843.196% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -189.942% |
| Immunic, Inc. | 25.36 Million USD | -986.676% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -298.157% |
| Veracyte, Inc. | 93.71 Million USD | -194.143% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -10435.057% |
| FibroGen, Inc. | 585.72 Million USD | 52.936% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -1485.848% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -42110.707% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -4774.371% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 96.399% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -3262.625% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -228.09% |
| TG Therapeutics, Inc. | 169.08 Million USD | -63.035% |
| Galecto, Inc. | 5.89 Million USD | -4575.509% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -3227.716% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 89.472% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -856.45% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -2084.201% |
| XBiotech Inc. | 8.39 Million USD | -3182.934% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -1778.359% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -418.368% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | 24.081% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -925.398% |
| Theravance Biopharma, Inc. | 169 Million USD | -63.113% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 77.322% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | 44.913% |
| Vaxxinity, Inc. | 30.94 Million USD | -790.861% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 71.653% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -4470.77% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | 63.009% |
| NexImmune, Inc. | 5.08 Million USD | -5322.019% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -74125.216% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -8865.256% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 96.121% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -5248.591% |
| Scopus BioPharma Inc. | 7.45 Million USD | -3598.041% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -948.406% |
| Ainos, Inc. | 7.39 Million USD | -3628.154% |
| Pluri Inc. | 34.11 Million USD | -708.126% |
| Prothena Corporation plc | 135.01 Million USD | -104.173% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -13.396% |
| Celularity Inc. | 102.92 Million USD | -167.823% |
| Rallybio Corporation | 9.43 Million USD | -2821.45% |
| Cue Biopharma, Inc. | 24.44 Million USD | -1027.707% |
| MeiraGTx Holdings plc | 319.99 Million USD | 13.851% |
| Omeros Corporation | 403.25 Million USD | 31.639% |
| Humacyte, Inc. | 114.67 Million USD | -140.386% |
| Immunocore Holdings plc | 228.15 Million USD | -20.823% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -5554.728% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -259.223% |
| Blueprint Medicines Corporation | 918.64 Million USD | 69.992% |
| CalciMedica, Inc. | 4.02 Million USD | -6743.793% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -1479.578% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -78.839% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -221.228% |
| Sana Biotechnology, Inc. | 277.79 Million USD | 0.765% |
| Pulmatrix, Inc. | 15.96 Million USD | -1626.918% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -1647.721% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -1020.328% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -9.912% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -442.803% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 77.23% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -767.344% |
| Nutriband Inc. | 1.07 Million USD | -25450.389% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -2492.57% |
| Vor Biopharma Inc. | 59.1 Million USD | -366.412% |
| Roivant Sciences Ltd. | 773.95 Million USD | 64.382% |
| Evogene Ltd. | 17.99 Million USD | -1432.34% |
| ProKidney Corp. | 29.21 Million USD | -843.551% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -282.984% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -39002.787% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 85.406% |
| CorMedix Inc. | 11.91 Million USD | -2213.131% |
| BioLineRx Ltd. | 50.7 Million USD | -443.702% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -84.444% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -211.697% |
| Atai Life Sciences N.V. | 49.16 Million USD | -460.734% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -784.904% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -1434.729% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -121.178% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -4775.628% |
| MediciNova, Inc. | 3.89 Million USD | -6983.753% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -1408.113% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -18226.053% |
| GeoVax Labs, Inc. | 3.51 Million USD | -7731.742% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | 30.607% |
| Biomea Fusion, Inc. | 30.69 Million USD | -798.234% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 89.872% |
| Mereo BioPharma Group plc | 15.96 Million USD | -1627.027% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -783.523% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -369.75% |
| Absci Corporation | 58.3 Million USD | -372.811% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -1347.228% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -759.797% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -273.584% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -215.11% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -716.31% |
| Allakos Inc. | 74.79 Million USD | -268.575% |
| Imunon, Inc. | 8.53 Million USD | -3131.585% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -1125.137% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -140.104% |
| BioAtla, Inc. | 48.98 Million USD | -462.749% |
| NLS Pharmaceutics AG | 10.68 Million USD | -2481.112% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -9819.683% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -111.072% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -1839.275% |
| XOMA Corporation | 145.58 Million USD | -89.358% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -718.856% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -300.919% |
| aTyr Pharma, Inc. | 31.59 Million USD | -772.45% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -345.899% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -513.072% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -469.538% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -9505.157% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -3279.105% |
| Akari Therapeutics, Plc | 4.58 Million USD | -5913.7% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -1454.537% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 83.287% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -68150.196% |
| UroGen Pharma Ltd. | 243.52 Million USD | -13.2% |
| Sutro Biopharma, Inc. | 321.08 Million USD | 14.145% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -9882.336% |
| Orgenesis Inc. | 35.53 Million USD | -675.765% |
| Entera Bio Ltd. | 1.37 Million USD | -19890.428% |
| GH Research PLC | 6.7 Million USD | -4013.834% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -3953.941% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -1364.294% |
| Xencor, Inc. | 283.55 Million USD | 2.783% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -9133.021% |
| Replimune Group, Inc. | 113.21 Million USD | -143.493% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -7237.206% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -166.269% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -68150.196% |
| Portage Biotech Inc. | 4.45 Million USD | -6094.787% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -18226.053% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -1095.957% |
| OncoCyte Corporation | 49.29 Million USD | -459.187% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -6563.79% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -34467.214% |
| Purple Biotech Ltd. | 10 Million USD | -2655.302% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -4664.397% |
| scPharmaceuticals Inc. | 57.26 Million USD | -381.424% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -2125.279% |
| HilleVax, Inc. | 78.9 Million USD | -249.349% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -5358.772% |
| Tharimmune, Inc. | 1.81 Million USD | -15087.935% |
| Genprex, Inc. | 3.25 Million USD | -8371.124% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -916.512% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -5164.859% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -133719.417% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -76784.545% |
| OKYO Pharma Limited | 7.42 Million USD | -3614.779% |
| Savara Inc. | 37.19 Million USD | -641.202% |
| Curis, Inc. | 57.61 Million USD | -378.491% |
| Daré Bioscience, Inc. | 26.32 Million USD | -946.979% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -603.238% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -18990.582% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -1224.117% |
| BeiGene, Ltd. | 2.23 Billion USD | 87.659% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -1194.836% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -5.058% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -1195.798% |
| Erasca, Inc. | 78.61 Million USD | -250.674% |
| bluebird bio, Inc. | 424.62 Million USD | 35.08% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -41970.532% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 85.415% |
| DBV Technologies S.A. | 42.8 Million USD | -544.084% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -41970.532% |
| Moderna, Inc. | 4.57 Billion USD | 93.971% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -3840.929% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -16546.618% |
| Molecular Templates, Inc. | 31.17 Million USD | -784.373% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -1514.927% |
| Travere Therapeutics, Inc. | 588.1 Million USD | 53.126% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -121.411% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -904.731% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -656.166% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -395.494% |
| MacroGenics, Inc. | 154.2 Million USD | -78.765% |
| RenovoRx, Inc. | 4.46 Million USD | -6072.593% |
| Adicet Bio, Inc. | 37.12 Million USD | -642.64% |
| Prime Medicine, Inc. | 60.78 Million USD | -353.551% |
| Aditxt, Inc. | 28.53 Million USD | -866.186% |
| Adagene Inc. | 45.16 Million USD | -510.299% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -152454.773% |
| Quantum-Si incorporated | 26.63 Million USD | -935.139% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | 60.481% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -8960.76% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -139.793% |
| SciSparc Ltd. | 1.59 Million USD | -17183.26% |
| Vericel Corporation | 127.7 Million USD | -115.863% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -4853.697% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -222.955% |
| Generation Bio Co. | 171.63 Million USD | -60.618% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -2286.736% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -559.004% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -9.09% |
| Invivyd, Inc. | 51.71 Million USD | -433.073% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -199.714% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -4137.623% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -265.143% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -26899.804% |
| 2seventy bio, Inc. | 310.12 Million USD | 11.111% |
| ADMA Biologics, Inc. | 193.97 Million USD | -42.114% |
| Clene Inc. | 38.95 Million USD | -607.73% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -662.929% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -7.274% |
| GeoVax Labs, Inc. | 3.51 Million USD | -7731.742% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -44.888% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -2163.347% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -39.0% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -2160.537% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -472.983% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -421.693% |
| Vir Biotechnology, Inc. | 369.85 Million USD | 25.466% |
| Evaxion Biotech A/S | 17.61 Million USD | -1464.741% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -71.298% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -79.956% |
| Trevena, Inc. | 48.26 Million USD | -471.191% |
| Surrozen, Inc. | 8.14 Million USD | -3284.506% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -1176.536% |
| Cingulate Inc. | 10.36 Million USD | -2560.666% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -9924.291% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -639.215% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -7586.225% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -1996.335% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | 13.094% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -1009.373% |
| Clearmind Medicine Inc. | 3.61 Million USD | -7536.216% |
| Kronos Bio, Inc. | 54.2 Million USD | -408.603% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -485.992% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -1111.209% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -1273.464% |
| Statera Biopharma, Inc. | 22.67 Million USD | -1115.657% |
| ImmunityBio, Inc. | 1.09 Billion USD | 74.718% |
| Korro Bio, Inc. | 51.75 Million USD | -432.671% |
| Kineta, Inc. | 7.22 Million USD | -3717.059% |
| BioVie Inc. | 9.7 Million USD | -2741.314% |
| Codexis, Inc. | 49.94 Million USD | -451.932% |
| Celularity Inc. | 102.92 Million USD | -167.823% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -186.417% |
| Celcuity Inc. | 51.45 Million USD | -435.797% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -79758.862% |
| Cibus, Inc. | 206.11 Million USD | -33.743% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -549.012% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -946.615% |
| IN8bio, Inc. | 8.77 Million USD | -3042.59% |
| Kodiak Sciences Inc. | 213.59 Million USD | -29.063% |
| Annexon, Inc. | 47.11 Million USD | -485.059% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -207.868% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -186.046% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -1913.792% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 89.411% |
| Eyenovia, Inc. | 19.78 Million USD | -1293.651% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -55.669% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -3488.96% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -1043.898% |
| Arcellx, Inc. | 339.75 Million USD | 18.862% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -2216.927% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -12.27% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -2782.652% |
| Moolec Science SA | 13.94 Million USD | -1876.773% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -538.83% |
| Geron Corporation | 146.12 Million USD | -88.65% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -445.532% |
| Royalty Pharma plc | 6.29 Billion USD | 95.623% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -593.051% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -93535.32% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -11104.732% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -45.736% |
| Humacyte, Inc. | 114.67 Million USD | -140.386% |
| Structure Therapeutics Inc. | 29.05 Million USD | -848.91% |
| 89bio, Inc. | 59.96 Million USD | -359.73% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -941.711% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -22949.164% |
| Genelux Corporation | 8.42 Million USD | -3173.967% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -3920.828% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -102.223% |
| Notable Labs, Ltd. | 4.42 Million USD | -6126.971% |
| Liquidia Corporation | 73.13 Million USD | -276.915% |
| Mustang Bio, Inc. | 17.61 Million USD | -1464.606% |
| Immunovant, Inc. | 48.95 Million USD | -463.105% |
| Quantum-Si incorporated | 26.63 Million USD | -935.139% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -618.203% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -8783.919% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -273.225% |
| Acasti Pharma Inc. | 11.55 Million USD | -2285.29% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -1119.353% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -10040.796% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -647.534% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -20127.436% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -4422.113% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -1009.998% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -1089.044% |
| PepGen Inc. | 34.63 Million USD | -696.015% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -2169.993% |
| United Therapeutics Corporation | 1.18 Billion USD | 76.682% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -3847.136% |
| Solid Biosciences Inc. | 38.45 Million USD | -616.803% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -3121.477% |
| Immuneering Corporation | 12 Million USD | -2195.635% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -87732.077% |
| Silo Pharma, Inc. | 1.56 Million USD | -17466.639% |
| Belite Bio, Inc | 4.21 Million USD | -6446.379% |
| XOMA Corporation | 145.58 Million USD | -89.358% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -11253.707% |
| Bionomics Limited | 10.15 Million USD | -2613.609% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -1182.714% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -1103.107% |
| uniQure N.V. | 624.01 Million USD | 55.824% |
| Cassava Sciences, Inc. | 14.19 Million USD | -1842.008% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -152454.773% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -61.982% |
| Forte Biosciences, Inc. | 3.66 Million USD | -7419.585% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -105688.942% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -3985.786% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -3488.96% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -1485.848% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -2508.516% |
| Altimmune, Inc. | 16.54 Million USD | -1566.574% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | 55.372% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -1103.107% |
| Compugen Ltd. | 55.77 Million USD | -394.25% |
| Peak Bio, Inc. | 20.75 Million USD | -1228.305% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -149.557% |
| Benitec Biopharma Inc. | 4.96 Million USD | -5455.582% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -74.647% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -266.707% |
| Zura Bio Limited | 21.29 Million USD | -1194.702% |
| PolyPid Ltd. | 17.46 Million USD | -1478.131% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -145.258% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -266.707% |
| Instil Bio, Inc. | 99.8 Million USD | -176.218% |
| argenx SE | 444.95 Million USD | 38.045% |
| Immunome, Inc. | 28.65 Million USD | -861.923% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -3206.561% |
| Verona Pharma plc | 58.84 Million USD | -368.496% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -1804.705% |
| Shattuck Labs, Inc. | 14.85 Million USD | -1755.226% |
| CervoMed Inc. | 2.59 Million USD | -10519.987% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -5555.888% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -2064.479% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -2516.687% |
| Moolec Science SA | 13.94 Million USD | -1876.773% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -11663.069% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -395.848% |
| AnaptysBio, Inc. | 364.28 Million USD | 24.326% |
| Design Therapeutics, Inc. | 11.95 Million USD | -2205.688% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -2073.352% |
| NeurAxis, Inc. | 1.91 Million USD | -14312.212% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -608.148% |
| Lumos Pharma, Inc. | 13.33 Million USD | -1967.562% |
| Achilles Therapeutics plc | 19.08 Million USD | -1344.271% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -1804.705% |
| 180 Life Sciences Corp. | 5.38 Million USD | -5017.084% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -1068.679% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -1111.209% |
| Nutriband Inc. | 1.07 Million USD | -25450.389% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -800.935% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -1799.717% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | 31.302% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -748.914% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -2012.545% |
| Palisade Bio, Inc. | 2.73 Million USD | -9964.549% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -5147.82% |
| Beam Therapeutics Inc. | 478.38 Million USD | 42.375% |
| Neurogene Inc. | 36.54 Million USD | -654.242% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | 30.728% |
| AEON Biopharma, Inc. | 159.88 Million USD | -72.412% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -478.527% |
| Sesen Bio, Inc. | 30.98 Million USD | -789.711% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -961.854% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -3526.153% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -40.835% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -43.534% |
| Athira Pharma, Inc. | 30.05 Million USD | -817.151% |
| Vaccinex, Inc. | 5.94 Million USD | -4539.313% |
| HCW Biologics Inc. | 15.05 Million USD | -1731.445% |
| XOMA Corporation | 145.58 Million USD | -89.358% |
| Nektar Therapeutics | 267.04 Million USD | -3.229% |
| Arvinas, Inc. | 644.6 Million USD | 57.234% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -1454.537% |
| Merus N.V. | 102.15 Million USD | -169.863% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -88.362% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -189.811% |
| Rezolute, Inc. | 11.73 Million USD | -2249.31% |
| Clene Inc. | 38.95 Million USD | -607.73% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -9581.462% |
| BeyondSpring Inc. | 48.26 Million USD | -471.108% |
| Synlogic, Inc. | 32.89 Million USD | -738.024% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -1786.457% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -16770.747% |
| Peak Bio, Inc. | 20.75 Million USD | -1228.305% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -334.403% |
| Krystal Biotech, Inc. | 39.71 Million USD | -594.133% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | 26.809% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -176.861% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -63604.977% |
| MannKind Corporation | 721.36 Million USD | 61.785% |
| Ikena Oncology, Inc. | 22.33 Million USD | -1134.242% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -13115.149% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -168.708% |
| Gossamer Bio, Inc. | 249.14 Million USD | -10.645% |
| CohBar, Inc. | 1.03 Million USD | -26569.685% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -2478.988% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -1347.228% |
| Legend Biotech Corporation | 589.93 Million USD | 53.271% |
| Mural Oncology plc | 37.92 Million USD | -626.819% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -107.838% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -11909.94% |
| Disc Medicine, Inc. | 22.87 Million USD | -1105.106% |
| Champions Oncology, Inc. | 28.03 Million USD | -883.299% |
| REGENXBIO Inc. | 262.22 Million USD | -5.125% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -8105.987% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -2099.362% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -1952.38% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -1200.014% |
| Vaxart, Inc. | 34.02 Million USD | -710.193% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -1252.025% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -866.175% |
| Cellectis S.A. | 249.57 Million USD | -10.455% |
| Longeveron Inc. | 5.33 Million USD | -5065.224% |
| Repare Therapeutics Inc. | 41.81 Million USD | -559.193% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 88.539% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -356.646% |
| Revolution Medicines, Inc. | 262.39 Million USD | -5.058% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -12983.436% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -3095.78% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -2235.972% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -1863.028% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -12715.807% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 94.647% |
| Denali Therapeutics Inc. | 122.96 Million USD | -124.188% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -4853.697% |
| Veru Inc. | 32.81 Million USD | -740.126% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -3913.219% |
| Cingulate Inc. | 10.36 Million USD | -2560.666% |
| Passage Bio, Inc. | 39.26 Million USD | -602.124% |
| Context Therapeutics Inc. | 4.19 Million USD | -6476.497% |
| Exicure, Inc. | 8.54 Million USD | -3124.564% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -834.214% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -2528.915% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -1150.706% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -69.136% |
| Nuvalent, Inc. | 31.82 Million USD | -766.254% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -4233.294% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -337.416% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -1431.489% |
| OmniAb, Inc. | 87.4 Million USD | -215.41% |
| Anew Medical, Inc. | 8.24 Million USD | -3244.755% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -619.965% |
| Lipocine Inc. | 2.63 Million USD | -10375.185% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -949.284% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -585.537% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -934.719% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -219.971% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -5004.018% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -233.146% |
| Ocugen, Inc. | 23.98 Million USD | -1049.431% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -494.022% |
| Q32 Bio Inc. | 233.12 Million USD | -18.247% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -2940.679% |
| Alumis Inc. Common Stock | 53.5 Million USD | -415.248% |
| Equillium, Inc. | 27.95 Million USD | -886.043% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -33.436% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -4799.314% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -4394.855% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -75.221% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -297.027% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -2663.81% |
| Dominari Holdings Inc. | 4.63 Million USD | -5847.53% |
| Edesa Biotech, Inc. | 1.84 Million USD | -14868.639% |
| vTv Therapeutics Inc. | 29.56 Million USD | -832.35% |
| Bio-Techne Corporation | 744.34 Million USD | 62.965% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -118.612% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | 19.97% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -579.404% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -851.991% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -198.471% |
| Nkarta, Inc. | 105.6 Million USD | -161.049% |
| BioCardia, Inc. | 4.59 Million USD | -5905.839% |
| Iterum Therapeutics plc | 32.66 Million USD | -744.002% |